TNYA — Tenaya Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1858848 ·
Last close
$0.78
Market Cap
$169.69M
52W High
$1.15
52W Low
$0.53
ADV30
4,388,465
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 225,000 | — | -20,065,000 | -19,272,000 | 135,070,000 | 80,887,000 | 28,881,000 |
| Dec 2025 | 0 | — | -20,775,000 | -20,175,000 | 146,921,000 | 100,547,000 | 23,656,000 |
| Sep 2025 | 0 | — | -20,936,000 | -20,275,000 | 104,980,000 | 56,312,000 | 22,112,000 |
| Jun 2025 | 0 | — | -24,082,000 | -23,283,000 | 122,151,000 | 62,671,000 | 22,323,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-68,264,000
Investing CF
$56,083,000
Financing CF
$108,405,000
CapEx
$-618,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.62
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-605,008,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-93,331,000
Pretax Income TTM
$-90,597,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$225,000
EBITDA
$-78,320,000
Free Cash Flow
$-41,898,248
Enterprise Value
$96,861,632
Total Cash
$80,887,000
Total Debt
$10,117,000
Shares Out
216,998,876
Trailing EPS
$-0.44
Book Value
$0.57
ROE
-73.6%
ROA
-38.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -93,331,000 | -90,597,000 | 146,921,000 | 23,656,000 | — | -68,264,000 |
| Dec 2024 | 0 | -115,948,000 | -111,129,000 | 119,940,000 | 27,086,000 | — | -90,501,000 |
| Dec 2023 | 0 | -131,193,000 | -124,084,000 | 170,515,000 | 31,091,000 | — | -102,072,000 |
| Dec 2022 | 0 | -125,621,000 | -123,665,000 | 278,945,000 | 35,569,000 | — | -104,424,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.41
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | $172.42M | $2.14 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $174.79M | $2.42 | — |
| IPHA | Innate Pharma SA | $161.51M | $1.72 | — |
| VXRT | Vaxart, Inc. | $153.22M | $0.63 | — |
| MOLN | MOLECULAR PARTNERS AG | $151.92M | $4.05 | — |
News headlines (Yahoo Finance, 1h cache)
High Growth Tech Stocks To Watch In The US May 2026
2026-05-22 11:38 · Yahoo
Exploring US High Growth Tech Stocks This May 2026
2026-05-15 11:38 · Yahoo
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
2026-05-15 10:01 · Yahoo
High Growth Tech Stocks in US for May 2026
2026-05-14 11:38 · Yahoo
Tenaya Therapeutics (TNYA) Is Up 26.6% After TN-401 Data Buzz and Narrower Losses Has The Bull Case Changed?
2026-05-11 19:13 · Yahoo
Exploring 3 High Growth Tech Stocks In The US Market
2026-05-11 11:38 · Yahoo
Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates
2026-05-06 21:25 · Yahoo
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-06 20:05 · Yahoo
High Growth Tech Stocks To Watch In US May 2026
2026-05-05 17:38 · Yahoo
High Growth Tech Stocks In US With Promising Potential
2026-05-04 11:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.